Go Pro
NYSE:PBH

Prestige Consumer Healthcare (PBH) Stock Price, News & Analysis

Prestige Consumer Healthcare logo
$45.99 -1.74 (-3.64%)
Closing price 03:59 PM Eastern
Extended Trading
$45.98 -0.02 (-0.04%)
As of 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Prestige Consumer Healthcare Stock (NYSE:PBH)

Advanced

Key Stats

Today's Range
$45.91
$47.46
50-Day Range
$44.92
$54.92
52-Week Range
$42.62
$71.07
Volume
503,902 shs
Average Volume
562,495 shs
Market Capitalization
$2.18 billion
P/E Ratio
12.88
Dividend Yield
N/A
Price Target
$70.75
Consensus Rating
Hold

Company Overview

Prestige Consumer Healthcare Inc. (NYSE: PBH) develops, markets and distributes over-the-counter health care products and household consumer products. Its portfolio includes branded treatments for eye care, gastrointestinal health, women’s health, oral care, respiratory conditions, pain relief and skin care, along with products for lice treatment and motion sickness.

The company’s brands include Clear Eyes, Dramamine, Monistat, Summer’s Eve, Compound W, Chloraseptic, Luden’s, BC, Goody’s, Nix and Hydralyte, among others. Prestige’s products are sold through retailers, drugstores, supermarkets, e-commerce channels and other distributors.

Prestige Consumer Healthcare is headquartered in Tarrytown, New York, and serves consumers primarily in the United States, with additional operations and distribution in markets including Canada and Australia. The company was formerly known as Prestige Brands Holdings and has expanded its business through the development and acquisition of established consumer health brands.

AI Generated. May Contain Errors.

Prestige Consumer Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
58th Percentile Overall Score

PBH MarketRank™: 

Prestige Consumer Healthcare scored higher than 58% of companies evaluated by MarketBeat, and ranked 345th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Prestige Consumer Healthcare has received a consensus rating of Hold. The company's average rating score is 2.17, and is based on no strong buy ratings, 2 buy ratings, 3 hold ratings, and 1 sell rating.

  • Upside Potential

    Prestige Consumer Healthcare has a consensus price target of $70.75, representing about 53.8% upside from its current price of $45.99.

  • Amount of Analyst Coverage

    Prestige Consumer Healthcare has only been the subject of 2 research reports in the past 90 days.

  • Read more about Prestige Consumer Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Prestige Consumer Healthcare are expected to grow by 11.62% in the coming year, from $4.56 to $5.09 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Prestige Consumer Healthcare is 12.88, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.02.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Prestige Consumer Healthcare is 12.88, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.58.

  • Price to Earnings Growth Ratio

    Prestige Consumer Healthcare has a PEG Ratio of 1.47. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Prestige Consumer Healthcare has a P/B Ratio of 1.15. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Prestige Consumer Healthcare's valuation and earnings.
  • Percentage of Shares Shorted

    9.82% of the float of Prestige Consumer Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Prestige Consumer Healthcare has a short interest ratio ("days to cover") of 11.05, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Prestige Consumer Healthcare has recently increased by 7.34%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Prestige Consumer Healthcare does not currently pay a dividend.

  • Dividend Growth

    Prestige Consumer Healthcare does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Prestige Consumer Healthcare will have a dividend payout ratio of 37.33% next year. This indicates that Prestige Consumer Healthcare will be able to sustain or increase its dividend.

  • News Sentiment

    Prestige Consumer Healthcare has a news sentiment score of 0.23. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.50 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Prestige Consumer Healthcare this week, compared to 4 articles on an average week.
  • Search Interest

    Only 2 people have searched for PBH on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Prestige Consumer Healthcare to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Prestige Consumer Healthcare insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    1.50% of the stock of Prestige Consumer Healthcare is held by insiders.

  • Percentage Held by Institutions

    99.95% of the stock of Prestige Consumer Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Prestige Consumer Healthcare's insider trading history.
Receive PBH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Prestige Consumer Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PBH Stock News Headlines

Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from collapsing — and billionaire Sam Altman is now an investor. This under-the-radar firm is drawing serious attention from those watching the energy infrastructure space closely.tc pixel
See More Headlines

PBH Stock Analysis - Frequently Asked Questions

Prestige Consumer Healthcare's stock was trading at $61.69 at the beginning of 2026. Since then, PBH stock has decreased by 25.4% and is now trading at $45.9940.

Prestige Consumer Healthcare Inc. (NYSE:PBH) issued its quarterly earnings data on Thursday, August, 6th. The company reported $0.98 EPS for the quarter, topping analysts' consensus estimates of $0.89 by $0.09. Prestige Consumer Healthcare's quarterly revenue was up 6.5% compared to the same quarter last year.
Read the conference call transcript
.

Top institutional shareholders of Prestige Consumer Healthcare include BlackRock Inc. (16.53%), Rice Hall James & Associates LLC (1.46%), The Manufacturers Life Insurance Company (1.39%) and Bank of America Corp DE (1.17%). Insiders that own company stock include Ronald M Lombardi, Jeffrey Zerillo, William P'pool, Adel Mekhail and Mary Beth Fritz.
View institutional ownership trends
.

Shares of PBH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Prestige Consumer Healthcare investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AUO (AUOTY).

Company Calendar

Last Earnings
8/06/2026
Today
9/23/2026
Small-Cap Virtual Conference
9/24/2026
Next Earnings (Estimated)
11/05/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Pharmaceuticals
Sub-Industry
Pharmaceuticals
Current Symbol
NYSE:PBH
CIK
1295947
Employees
890
Year Founded
1996

Price Target and Rating

High Price Target
$80.00
Low Price Target
$65.00
Potential Upside/Downside
+53.8%
Consensus Rating
Hold
Rating Score (0-4)
2.17
Research Coverage
6 Analysts

Profitability

EPS (Trailing Twelve Months)
$3.57
Trailing P/E Ratio
12.88
Forward P/E Ratio
10.09
P/E Growth
1.47
Net Income
$190.30 million
Net Margins
15.57%
Pretax Margin
21.20%
Return on Equity
11.39%
Return on Assets
5.66%

Debt

Debt-to-Equity Ratio
1.06
Current Ratio
3.23
Quick Ratio
1.99

Sales & Book Value

Annual Sales
$1.09 billion
Price / Sales
2.00
Cash Flow
$5.12 per share
Price / Cash Flow
8.99
Book Value
$39.89 per share
Price / Book
1.15

Miscellaneous

Outstanding Shares
47,380,000
Free Float
46,664,000
Market Cap
$2.18 billion
Optionable
Optionable
Beta
0.33

Social Links

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

This page (NYSE:PBH) was last updated on 9/23/2026 by MarketBeat.com Staff.
From Our Partners